Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Grothey

Showing results (151-160 of 304) with videos related to

Pageof 31
Sort By:
Cancer Management and Research|July 21, 2021
Effect of Regorafenib in Delaying Definitive Deterioration in Health-Related Quality of Life in Patients with Advanced Cancer of Three Different Tumor TypesRalf-Dieter Hofheinz, Jordi Bruix, George D Demetri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
Comparison of error rates in single-arm versus randomized phase II cancer clinical trialsHui Tang, Nathan R Foster, Axel Grothey, et al.
The Cochrane Database of Systematic Reviews|March 19, 2010
Chemotherapy for advanced gastric cancerAnna Dorothea Wagner, Susanne Unverzagt, Wilfried Grothe, et al.
Journal of Pain and Symptom Management|September 29, 2012
A home-based exercise program to improve function, fatigue, and sleep quality in patients with Stage IV lung and colorectal cancer: a randomized controlled trialAndrea L Cheville, Jenny Kollasch, Justin Vandenberg, et al.
The Lancet. Oncology|April 17, 2016
Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254Gita Thanarajasingam, Pamela J Atherton, Paul J Novotny, et al.
Journal of Geriatric Oncology|September 18, 2017
Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance)Nadine J McCleary, Joleen Hubbard, Michelle R Mahoney, et al.
Case Reports in Oncological Medicine|June 20, 2015
Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal CancerPashtoon Murtaza Kasi, Gita Thanarajasingam, Heidi D Finnes, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2012
Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: results from a large treatment observational cohort studyFairooz F Kabbinavar, Patrick J Flynn, Mark Kozloff, et al.
Seminars in Oncology|February 23, 2010
Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of two widely used prognostic calculatorsAditya Bardia, Charles Loprinzi, Axel Grothey, et al.
Oncology|August 25, 2010
Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort studyMark F Kozloff, Jordan Berlin, Patrick J Flynn, et al.
Pageof 31

Showing results (151-160 of 304) with videos related to

Sort By:
Pageof 31
Cancer Management and Research|July 21, 2021
Effect of Regorafenib in Delaying Definitive Deterioration in Health-Related Quality of Life in Patients with Advanced Cancer of Three Different Tumor TypesRalf-Dieter Hofheinz, Jordi Bruix, George D Demetri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
Comparison of error rates in single-arm versus randomized phase II cancer clinical trialsHui Tang, Nathan R Foster, Axel Grothey, et al.
The Cochrane Database of Systematic Reviews|March 19, 2010
Chemotherapy for advanced gastric cancerAnna Dorothea Wagner, Susanne Unverzagt, Wilfried Grothe, et al.
Journal of Pain and Symptom Management|September 29, 2012
A home-based exercise program to improve function, fatigue, and sleep quality in patients with Stage IV lung and colorectal cancer: a randomized controlled trialAndrea L Cheville, Jenny Kollasch, Justin Vandenberg, et al.
The Lancet. Oncology|April 17, 2016
Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254Gita Thanarajasingam, Pamela J Atherton, Paul J Novotny, et al.
Journal of Geriatric Oncology|September 18, 2017
Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance)Nadine J McCleary, Joleen Hubbard, Michelle R Mahoney, et al.
Case Reports in Oncological Medicine|June 20, 2015
Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal CancerPashtoon Murtaza Kasi, Gita Thanarajasingam, Heidi D Finnes, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2012
Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: results from a large treatment observational cohort studyFairooz F Kabbinavar, Patrick J Flynn, Mark Kozloff, et al.
Seminars in Oncology|February 23, 2010
Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of two widely used prognostic calculatorsAditya Bardia, Charles Loprinzi, Axel Grothey, et al.
Oncology|August 25, 2010
Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort studyMark F Kozloff, Jordan Berlin, Patrick J Flynn, et al.
Pageof 31